Ghosez et al.
1835
(CDCl3, 500 MHz) d: 7.87 (dd, 3J = 8.0 Hz, 4J = 1.3 Hz, 1H,
CHCHC(CHCH)2CH), 7.45 (d, 3J
=
8.3 Hz, 2H,
NO2CCHCHCH), 7.63 (d, 3J
=
8.0 Hz, 2H,
CHC(CHCH)2CH), 7.35 (t, 3J = 8.3 Hz, 2H, CHC(CHCH)2CH),
7.33 (d, 3J = 3.4 Hz, 1H, NCHCH), 7.27–7.25 (m, 1H,
CHC(CHCH)2CH), 7.23 (d, 3J = 8.5 Hz, 2H, NSO2C-
(CHCH)2CCH3), 6.78 (d, 3J = 15.5 Hz, 1H, CHCHC-
3
4
NSO2C(CHCH)2CCH3), 7.50 (dt, J = 7.7 Hz, J = 1.4 Hz,
1H, NO2CHCHCH), 7.41 (dt, J = 7.7 Hz, J = 1.4 Hz, 1H,
NO2CHCHCH), 7.41 (d, J = 3.4 Hz, 1H, NCHCH), 7.37
(dd, J = 7.9 Hz, J = 1.3 Hz, 1H, NO2CCCH), 7.30 (d, J =
16.5 Hz, 1H, CHCHC(CHCH)2CH), 7.28–7.20 (m, 3H,
CHC(CHCH)2CH), 7.22 (d, 3J = 8.0 Hz, 2H, NSO2C-
(CHCH)2CCH3), 7.16–7.14 (m, 2H, CHC(CHCH)2CH), 6.24
3
4
3
3
4
3
3
(CHCH)2CH), 6.27 (d, J = 3.4 Hz, 1H, NCHCH), 2.35 (s,
3H, CH3). 13C NMR (CDCl3, 125 MHz) d: 144.85
(NSO2C(CHCH)2CCH3), 136.94 (CHC(CHCH)2CH), 135.93
(NSO2C(CHCH)2CCH3), 133.84 (NCCH), 127.63 (CHCHC-
(CHCH)2CH), 129.80 (NSO2C(CHCH)2CCH3), 129.56
(CHC(CHCH)2CH), 128.60 (CHCHC(CHCH)2CH), 126.77
(NSO2C(CHCH)2CCH3), 126.33 (CHCHC(CHCH)2CH), 123.23
(NCHCH), 116.79 (CHCHC(CHCH)2CH), 112.38 (NCHCH),
111.34 (t, NCCD), 21.47 (CH3).
3
3
(d, J = 3.4 Hz, 1H, NCHCH), 6.02 (d, J = 16.5 Hz, 1H,
CHCHC(CHCH)2CH), 2.35 (s, 3H, CH3). 13C NMR (CDCl3,
125 MHz) d: 149.48 (CNO2), 145.07 (NSO2C(CHCH)2CCH3),
136.62 (CHC(CHCH)2CH), 135.77 (NSO2C(CHCH)2CCH3),
134.00 (CHC(CHCH)2CH), 132.64 (CHCCNO2), 132.60
(CHCHCHCCNO2), 130.36 (CCNO2), 129.80 (NSO2C-
(CHCH)2CCH3), 129.75 (NCC), 128.47 (CHCHC(CHCH)2-
CH), 128.17 (NO2CCHCH), 127.90 (CHCHC(CHCH)2CH),
126.87 (NSO2C(CHCH)2CCH3), 126.23 (CHCHC(CHCH)2CH),
124.2 (NO2CCCH), 123.30 (NCC), 122.93 (NCHCH),
115.85 (CHCHC(CHCH)2CH), 113.82 (NCHCH), 21.60
(CH3).
2-Formyl-3-(o-nitrophenyl)-1-tosylpyrrole (13a) (RN:
233770-18-8)
Method C: 120 mg (0.32 mmol) of the 3-iodo-2-formyl-1-
tosylpyrrole 7b, 80 mg (0.48 mmol) of o-nitrophenylboronic
acid, 150 mg (0.48 mmol) of barium hydroxide octahydrate,
23 mg (0.032 mmol) of dichloro(diphenylphosphinoferrocene)pal-
ladium(II). Eluent: 30% diethyl ether in petroleum ether.
Yield of 13a: 120 mg, 98%, pale yellow solid (mp 143°C).
Rf = 0.29 (40% diethyl ether in petroleum ether). MS (EI)
m/z: 369 (8, M+), 341 (42, [M – CO]+), 324 (38, [M –
NO2]+), 215 (100, [M – C7H7SO2]+), 187 (50, [215 – CO]+),
155 (47, [C7H7SO2]+), 91 (88, [C7H7]+). IR: 3074, 1678,
1536, 1269, 740. 1H NMR (CDCl3, 500 MHz) d: 9.88 (s, 1H,
2-Styryl-1-tosylpyrrole (11) and 3-[2H]-2-styryl-1-tosylpyrrole
(d-11)
To 3-iodo-2-styryl-1-tosylpyrrole 6b (100 mg, 0.22 mmol),
barium hydroxide octahydrate (1.5 equiv), and catalyst (0.05
or 0.1 equiv), a degassed mixture of DMF (8 mL) and water
(2 mL) was added. The mixture was then placed in a bath
preheated to 120°C. After 20 min, it was cooled to room
temperature and diluted with ethyl acetate and water. After
filtration on a Celite® pad (washed with ethyl acetate), the
solution was washed with water, brine, and dried. Purifica-
tion by flash chromatography on silica gel (20% diethyl
ether in petroleum ether). Yield of 11: 57 mg, 79%, colour-
less oil. Rf = 0.38 (30% diethyl ether in petroleum ether).
MS (EI) m/z: 323 (100, M+), 168 (54, [M – C7H7SO2]+).
HRMS calcd. for C19H17NO2S: 323.0980; found: 323.0979.
3
4
CHO), 8.04 (dd, J = 8.1 Hz, J = 1.5 Hz, 1H, CHCNO2),
3
7.79 (d, J = 8.1 Hz, 2H, NSO2C(CHCH)2CCH3), 7.67 (d,
3J = 3.3 Hz, 1H, NCHCH), 7.59 (td, J = 7.7 Hz, J =
3
4
3
4
1.4 Hz, 1H, NO2CCHCHCH), 7.52 (td, J = 7.7 Hz, J =
1.4 Hz, 1H, NO2CCHCH), 7.35 (d, 3J = 8.1 Hz, 2H,
3
4
NSO2C(CHCH)2CCH3), 7.33 (dd, J = 7.7 Hz, J = 1.4 Hz,
3
1H, NO2CCCH), 6.39 (d, J = 3.3 Hz, 1H, NCHCH), 2.43
(s, 3H, CH3). 13C NMR (CDCl3, 125 MHz) d: 178.9 (CHO),
148.98 (CNO2), 145.98 (NSO2C(CHCH)2CCH3), 135.42
3
1H NMR (CDCl3, 500 MHz) d: 7.68 (d, J = 8.5 Hz, 2H,
(NSO2C(CHCH)2CCH3), 135.26 (NCCHO),
132.44
(NSO2C(CHCH)2CCH3), 7.55 (d, 3J = 15.5 Hz, 1H,
CHCHC(CHCH)2CH), 7.45 (d, 3J = 8.3 Hz, 2H, CHC-
(CHCH)2CH), 7.35 (dd (t), 3J = 8.3 Hz, 2H, CHC-
(CHCH)2CH), 7.33 (dd, 3J = 3.4 Hz, 4J = 1.6 Hz, 1H,
NCHCH), 7.30–7.26 (m, 1H, CHC(CHCH)2CH), 7.23 (d,
3J = 8.5 Hz, 2H, NSO2C(CHCH)2CCH3), 6.78 (d, 3J =
(NO2CCHCHCH), 132.25 (NO2CCCH), 130.15 (NSO2C-
(CHCH)2CCH3), 129.2 (NO2CCHCH), 128.48 (NO2CC),
128.34 (NCC), 128.34 (NCH), 127.24 (NSO2C-
(CHCH)2CCH3), 124.39 (CHCNO2), 113.85 (NCHCH), 21.59
(CH3). Anal. calcd. for C18H14N2O5S: C 58.37, H 3.81,
N 7.56; found: C 58.23, H 3.56, N 7.37.
3
15.5 Hz, 1H, CHCHC(CHCH)2CH), 6.52 (dd, J = 3.4 Hz,
4J = 1.6 Hz, 1H, NCCH), 6.27 (t, 3J = 3.4 Hz, 1H, NCHCH),
2.35 (s, 3H, CH3). 13C NMR (CDCl3, 125 MHz) d: 144.85
(NSO2C(CHCH)2CCH3), 136.94 (CHC(CHCH)2CH), 135.93
(NSO2C(CHCH)2CCH3), 129.80 (NSO2C(CHCH)2CCH3),
129.56 (CHC(CHCH)2CH), 128.60 (CHCHC(CHCH)2CH),
128.20 (NCCH), 127.63 (CHCHC(CHCH)2CH), 126.77
(NSO2C(CHCH)2CCH3), 126.33 (CHCHC(CHCH)2CH),
123.23 (NCHCH), 116.79 (CHCHC(CHCH)2CH), 112.46
(NCHCH), 111.56 (NCCH), 21.47 (CH3).
2-Formyl-3-phenyl-1-tosylpyrrole (13b)
Method C: 150 mg (0.4 mmol) of the 3-iodo-2-formyl-1-
tosylpyrrole 7b, 73 mg (0.6 mmol) of phenylboronic acid,
189 mg (0.6 mmol) of barium hydroxide octahydrate, 30 mg
(0.04 mmol) of dichloro(diphenylphosphinoferrocene)palla-
dium(II). Eluent: 30% diethyl ether in petroleum ether. Yield
of 13b: 120 mg, 92%, white solid (mp 175°C). Rf = 0.37
(40% diethyl ether in petroleum ether). MS (EI) m/z: 325
C+
When using deuterated DMF-d7, d-11 was obtained. Rf =
0.38 (30% diethyl ether in petroleum ether). MS (EI) m/z:
(78, M ), 260 (45, [M – SO2]+), 170 (100, [M –
C7H7SO2]+), 169 (75), 155 (38, [C7H7SO2]+), 115 (41), 91
(53, [C7H7]+). HRMS calcd. for C18H151NO3S: 325.0772;
found: 325.0765. IR: 1675, 1374, 1174. H NMR (CDCl3,
C+
324 (38, M+), 169 (100, [M – C7H7SO2] ), 168 (58, [M-D +
H-C7H7SO2]+), 91 (24, [C7H7]+), 44 (64). HRMS calcd. for
C19H16DNO2S: 324.1042; found: 324.1048. 1H NMR
(CDCl3, 500 MHz) d: 7.68 (d, 3J = 8.5 Hz, 2H,
(NSO2C(CHCH)2CCH3), 7.55 (d, 3J = 15.5 Hz, 1H,
3
500 MHz) d: 9.62 (s, 1H, COH), 7.94 (d, J = 8.8 Hz, 2H,
(NSO2C(CHCH)2CCH3), 7.84 (d, 3J = 3.4 Hz, 1H, NCHCH),
3
7.40 (s, 5H), 7.34 (d, J = 8.8 Hz, 2H, NSO2C(CHCH)2CCH3),
© 2001 NRC Canada